Isothermal Nucleic Acid Amplification Market Size, Share, Trends, Growth Outlook

Isothermal Nucleic Acid Amplification Market is estimated to increase at a Compounded Annual Growth Rate of 9.6% CAGR over the forecast period from 2024 to 2030

The Isothermal Nucleic Acid Amplification Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Technology (Helicase-dependent Amplification (HDA), Nicking Enzyme Amplification Reaction (NEAR), Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification (NASBA), Transcription Mediated Amplification (TMA), Single Primer Isothermal Amplification (SPIA), Others), By Product (Instruments, Reagents), By End-User (Hospitals, Research Laboratories, Others).

An Introduction to Isothermal Nucleic Acid Amplification Market in 2024

In 2024, the market for isothermal nucleic acid amplification technologies continues to advance, offering rapid, sensitive, and cost-effective methods for the detection of infectious diseases, genetic disorders, and molecular biomarkers in clinical and research settings. Isothermal amplification techniques, such as loop-mediated isothermal amplification (LAMP), nucleic acid sequence-based amplification (NASBA), and recombinase polymerase amplification (RPA), enable the amplification of nucleic acid targets at a constant temperature without the need for sophisticated thermal cycling equipment. These methods provide significant advantages over traditional polymerase chain reaction (PCR) techniques, including shorter assay times, simplified instrumentation requirements, and increased tolerance to sample inhibitors. With applications ranging from point-of-care diagnostics to environmental monitoring and food safety testing, isothermal nucleic acid amplification technologies are driving innovation and expanding access to molecular testing worldwide. As the demand for rapid and accurate molecular diagnostics continues to grow, the market for isothermal nucleic acid amplification is poised for sustained growth and diversification, addressing emerging healthcare challenges and facilitating timely clinical decision-making.

Market Trend: Increasing Demand for Point-of-Care Testing

A prominent trend in the isothermal nucleic acid amplification market is the increasing demand for point-of-care testing. Point-of-care testing offers several advantages, including rapid results, ease of use, and accessibility outside of traditional laboratory settings. Isothermal nucleic acid amplification techniques, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), enable sensitive and specific detection of nucleic acids at a constant temperature, eliminating the need for complex thermal cycling equipment. The shift towards point-of-care testing reflects a growing need for timely diagnosis and surveillance of infectious diseases, particularly in resource-limited settings and during outbreaks or emergencies.

Market Driver: Demand for Rapid and Accurate Molecular Diagnostics

A key driver for the isothermal nucleic acid amplification market is the demand for rapid and accurate molecular diagnostics. Traditional nucleic acid amplification techniques, such as polymerase chain reaction (PCR), require complex instrumentation and temperature cycling, which can be time-consuming and impractical for on-site testing. Isothermal amplification methods offer advantages in terms of simplicity, speed, and portability, making them ideal for molecular diagnostics applications where rapid and accurate results are critical. The ability of isothermal nucleic acid amplification techniques to detect target nucleic acids with high sensitivity and specificity drives their adoption in various fields, including infectious disease diagnostics, food safety testing, and environmental monitoring.

Market Opportunity: Expansion into Near-Patient and Field-Based Testing

An emerging opportunity in the isothermal nucleic acid amplification market lies in the expansion into near-patient and field-based testing applications. Near-patient testing refers to diagnostic testing performed close to the patient's location, such as in outpatient clinics, emergency departments, or community healthcare settings. Field-based testing involves diagnostic testing conducted in remote or challenging environments, such as field hospitals, disaster relief operations, or resource-limited settings without access to traditional laboratory facilities. Isothermal nucleic acid amplification technologies offer advantages for near-patient and field-based testing scenarios due to their simplicity, rapidity, and minimal equipment requirements. By developing portable and user-friendly isothermal amplification platforms tailored for near-patient and field-based testing applications, manufacturers can address unmet needs for rapid and accessible molecular diagnostics in diverse healthcare and field settings, thereby expanding their market reach and contributing to improved healthcare outcomes.

Isothermal Nucleic Acid Amplification Market Share Analysis: Loop-mediated Isothermal Amplification (LAMP)

In the Isothermal Nucleic Acid Amplification Market, the segment experiencing the fastest growth is Loop-mediated Isothermal Amplification (LAMP). LAMP technology is a powerful molecular biology technique used for the rapid amplification of nucleic acids under isothermal conditions. It offers several advantages, including simplicity, rapidity, high sensitivity, and specificity, making it well-suited for various applications in molecular diagnostics, infectious disease detection, food safety testing, and environmental monitoring. LAMP technology utilizes a set of four to six primers and a strand-displacing DNA polymerase to amplify target nucleic acid sequences with high efficiency and minimal equipment requirements. With increasing demand for rapid and accurate nucleic acid amplification techniques, particularly in resource-limited settings and point-of-care environments, there is a growing adoption of LAMP technology in hospitals, research laboratories, and other healthcare facilities. Additionally, ongoing advancements in LAMP assay design, reagent formulations, and instrument automation further contribute to the segment's rapid growth in the Isothermal Nucleic Acid Amplification Market. Consequently, the LAMP technology segment is poised for significant expansion in the market.

Isothermal Nucleic Acid Amplification Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossBecton, Dickinson and Company, bioMérieux SA, Eiken Chemical Co. Ltd, Lucigen Corp, Meridian Bioscience Inc, OptiGene Ltd, QIAGEN N.V., Quidel Corp, Tecan Genomics Inc

Isothermal Nucleic Acid Amplification Market Segmentation

By Technology
Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
By Product
Instruments
Reagents
By End-User
Hospitals
Research Laboratories
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Isothermal Nucleic Acid Amplification Market Companies

Becton, Dickinson and Company
bioMérieux SA
Eiken Chemical Co. Ltd
Lucigen Corp
Meridian Bioscience Inc
OptiGene Ltd
QIAGEN N.V.
Quidel Corp
Tecan Genomics Inc

Reasons to Buy the Isothermal Nucleic Acid Amplification Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Isothermal Nucleic Acid Amplification Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Isothermal Nucleic Acid Amplification Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Isothermal Nucleic Acid Amplification Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Isothermal Nucleic Acid Amplification Market Size Outlook, $ Million, 2021 to 2030
3.2 Isothermal Nucleic Acid Amplification Market Outlook by Type, $ Million, 2021 to 2030
3.3 Isothermal Nucleic Acid Amplification Market Outlook by Product, $ Million, 2021 to 2030
3.4 Isothermal Nucleic Acid Amplification Market Outlook by Application, $ Million, 2021 to 2030
3.5 Isothermal Nucleic Acid Amplification Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Isothermal Nucleic Acid Amplification Industry
4.2 Key Market Trends in Isothermal Nucleic Acid Amplification Industry
4.3 Potential Opportunities in Isothermal Nucleic Acid Amplification Industry
4.4 Key Challenges in Isothermal Nucleic Acid Amplification Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Isothermal Nucleic Acid Amplification Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Isothermal Nucleic Acid Amplification Market Outlook by Segments
7.1 Isothermal Nucleic Acid Amplification Market Outlook by Segments, $ Million, 2021- 2030
By Technology
Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
By Product
Instruments
Reagents
By End-User
Hospitals
Research Laboratories
Others

8 North America Isothermal Nucleic Acid Amplification Market Analysis and Outlook To 2030
8.1 Introduction to North America Isothermal Nucleic Acid Amplification Markets in 2024
8.2 North America Isothermal Nucleic Acid Amplification Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Isothermal Nucleic Acid Amplification Market size Outlook by Segments, 2021-2030
By Technology
Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
By Product
Instruments
Reagents
By End-User
Hospitals
Research Laboratories
Others

9 Europe Isothermal Nucleic Acid Amplification Market Analysis and Outlook To 2030
9.1 Introduction to Europe Isothermal Nucleic Acid Amplification Markets in 2024
9.2 Europe Isothermal Nucleic Acid Amplification Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Isothermal Nucleic Acid Amplification Market Size Outlook by Segments, 2021-2030
By Technology
Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
By Product
Instruments
Reagents
By End-User
Hospitals
Research Laboratories
Others

10 Asia Pacific Isothermal Nucleic Acid Amplification Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Isothermal Nucleic Acid Amplification Markets in 2024
10.2 Asia Pacific Isothermal Nucleic Acid Amplification Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Isothermal Nucleic Acid Amplification Market size Outlook by Segments, 2021-2030
By Technology
Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
By Product
Instruments
Reagents
By End-User
Hospitals
Research Laboratories
Others

11 South America Isothermal Nucleic Acid Amplification Market Analysis and Outlook To 2030
11.1 Introduction to South America Isothermal Nucleic Acid Amplification Markets in 2024
11.2 South America Isothermal Nucleic Acid Amplification Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Isothermal Nucleic Acid Amplification Market size Outlook by Segments, 2021-2030
By Technology
Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
By Product
Instruments
Reagents
By End-User
Hospitals
Research Laboratories
Others
12 Middle East and Africa Isothermal Nucleic Acid Amplification Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Isothermal Nucleic Acid Amplification Markets in 2024
12.2 Middle East and Africa Isothermal Nucleic Acid Amplification Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Isothermal Nucleic Acid Amplification Market size Outlook by Segments, 2021-2030
By Technology
Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
By Product
Instruments
Reagents
By End-User
Hospitals
Research Laboratories
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Becton, Dickinson and Company
bioMérieux SA
Eiken Chemical Co. Ltd
Lucigen Corp
Meridian Bioscience Inc
OptiGene Ltd
QIAGEN N.V.
Quidel Corp
Tecan Genomics Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Technology
Helicase-dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
By Product
Instruments
Reagents
By End-User
Hospitals
Research Laboratories
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)